PDCD1 and familial pancreatic carcinoma: The decision to examine MAPK was based on several factors including prior observations in T cells demonstrating PD-1 regulation of MAPK and PI-3K/AKT pathways,29 which are critical signaling pathways in pancreatic cancer pathogenesis and progression.